Responses to Clonidine in Acute and Remitted Depressed Patients
A variety of studies reporting abnormal hormone responses to noradrenergic challenges point toward the possibility that a blunted growth hormone response to clonidine, reflecting decreased a2-adrenergic responsiveness, may constitute a trait or vulnerability marker for depression. These results contrast with preliminary data suggesting greater state dependence of indices of noradrenergic output, such as concentrations of the noradrenergic metabolite 3-methoxy-4-hydroxy-phenylglycol (MHPG) and hormones such as cortisol in biologic fluids.
KeywordsGrowth Hormone Depressed Patient Growth Hormone Response Average Growth Hormone Vulnerability Marker
Unable to display preview. Download preview PDF.
- Carpenter WT, Bunney WE (1971) Adrenal cortical activity in depressive illness. Am J Psychiatry 128:63–72.Google Scholar
- Carroll BJ (1972) Studies with hypothalamic-pituitary-adrenal stimulation tests in depression. In: Davis B, Barroll BJ, Mowbray RM (eds) Depressive illness: some research studies. C. C. Thomas, Springfield, pp 149–201.Google Scholar
- Checkley SA (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med 35-53.Google Scholar
- Checkley SA, Slade AP, Shur E (1981) Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 138:51.Google Scholar
- Endo M, Endo J, Nishikubo M, Yamaguchi T, Hatotani N (1974) Endocrine studies in depression. In: Hatotani N (ed) Psychoneuroendocrinology. Workshop conference of the international society for psychoneuroendocrinology. S. Karger, Basel, pp 22–31.Google Scholar
- Langer G, Heinze G, Reim B, Matussek N (1976) Reduced growth hormone responses to amphetamine in “endogenous” depressive patients: studies in normal, “reactive and endogenous” depressive, schizophrenic, and chronic alcoholic subjects. Arch Gen Psychiatry 33-1471.Google Scholar
- Lenox RH, Shipley JE, Peyser JM, Weaver LA, Armstrong CB, Astrikaga T (1983) Longitudinal neuroendocrine response in depression. New Research Abstracts of the American Psychiatric Association. NR 32.Google Scholar
- Martin JB, Reichlin S, Brown GM (1977) Clinical neuroendocrinology. F. A. Davis, Philadelphia.Google Scholar
- Sachar EJ, Asnis G, Nathan RS, Halbreich U, Tabriz BA, Halpern FS (1981) Dextroamphetamine and cortisol on depression. Arch Gen Psychiatry 37:755.Google Scholar